Beyond chip: Ccrs predicts prolonged cytopenias and inferior survival following anti-BCMA CAR-T in multiple myeloma
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Zhuoer Xie, Omar Alexis Castaneda Puglianini, Taiga Nishihori, Ariel Grajales-Cruz, Peter Cheng, Brandon Blue, David Scheiber-Camoretti, Ken Harada, Emily Merritt, Daniel Deavila, Brandon Kale, Karla Feliciano Salva, David Kaldas, Lucas Lee, Kristy Matte, Todd Stinard, Lauren Peres, Rebecca Gonzalez, Himara Koelmeyer, Michael Jain, Seongseok Yun, David Sallman, Rami Komrokji, Eric Padron, Jeffrey Lancet, Fabiana Perna, Hien Liu, Rachid Baz, Melissa Alsina, Ciara Louise Freeman, Frederick Locke, Kenneth Shain, Doris Hansen, Dae Hyun Lee
Institution: Moffitt Cancer Center
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417010332